gamlingay pharmacy limited
gamlingay pharmacy limited Company Information
Company Number
05467439
Next Accounts
Dec 2025
Shareholders
rightpharm ltd
Group Structure
View All
Industry
Dispensing chemist in specialised stores
Registered Address
60a ashleigh mann, station road, north harrow, HA2 7SL
Website
gamlingay.orggamlingay pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of GAMLINGAY PHARMACY LIMITED at £822.9k based on a Turnover of £2.5m and 0.33x industry multiple (adjusted for size and gross margin).
gamlingay pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of GAMLINGAY PHARMACY LIMITED at £424.3k based on an EBITDA of £107.9k and a 3.93x industry multiple (adjusted for size and gross margin).
gamlingay pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of GAMLINGAY PHARMACY LIMITED at £869.1k based on Net Assets of £416.3k and 2.09x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Gamlingay Pharmacy Limited Overview
Gamlingay Pharmacy Limited is a live company located in north harrow, HA2 7SL with a Companies House number of 05467439. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in May 2005, it's largest shareholder is rightpharm ltd with a 100% stake. Gamlingay Pharmacy Limited is a mature, small sized company, Pomanda has estimated its turnover at £2.5m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Gamlingay Pharmacy Limited Health Check
Pomanda's financial health check has awarded Gamlingay Pharmacy Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
4 Weak
Size
annual sales of £2.5m, make it smaller than the average company (£12.6m)
- Gamlingay Pharmacy Limited
£12.6m - Industry AVG
Growth
3 year (CAGR) sales growth of 49%, show it is growing at a faster rate (7.6%)
- Gamlingay Pharmacy Limited
7.6% - Industry AVG
Production
with a gross margin of 26.3%, this company has a comparable cost of product (31.3%)
- Gamlingay Pharmacy Limited
31.3% - Industry AVG
Profitability
an operating margin of 4.3% make it more profitable than the average company (2.5%)
- Gamlingay Pharmacy Limited
2.5% - Industry AVG
Employees
with 8 employees, this is below the industry average (62)
8 - Gamlingay Pharmacy Limited
62 - Industry AVG
Pay Structure
on an average salary of £26.6k, the company has an equivalent pay structure (£26.6k)
- Gamlingay Pharmacy Limited
£26.6k - Industry AVG
Efficiency
resulting in sales per employee of £311.6k, this is more efficient (£148.5k)
- Gamlingay Pharmacy Limited
£148.5k - Industry AVG
Debtor Days
it gets paid by customers after 84 days, this is later than average (29 days)
- Gamlingay Pharmacy Limited
29 days - Industry AVG
Creditor Days
its suppliers are paid after 36 days, this is quicker than average (64 days)
- Gamlingay Pharmacy Limited
64 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Gamlingay Pharmacy Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Gamlingay Pharmacy Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 30.8%, this is a lower level of debt than the average (59.1%)
30.8% - Gamlingay Pharmacy Limited
59.1% - Industry AVG
GAMLINGAY PHARMACY LIMITED financials
Gamlingay Pharmacy Limited's latest turnover from March 2024 is estimated at £2.5 million and the company has net assets of £416.3 thousand. According to their latest financial statements, Gamlingay Pharmacy Limited has 8 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | |||||||||||||||
| Tax | |||||||||||||||
| Profit After Tax | |||||||||||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | |||||||||||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | 8 | 5 | 6 | 7 | 7 | 7 | |||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 25,382 | 49,843 | 74,311 | 98,663 | 22,547 | 29,697 | 19,823 | 24,970 | 34,673 | 32,117 | 40,611 | 40,566 | 52,255 | 45,027 | 55,961 |
| Intangible Assets | 120,000 | 144,000 | 168,000 | 192,000 | 216,000 | 240,000 | 264,000 | 288,000 | 312,000 | 336,000 | 360,000 | ||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 25,382 | 49,843 | 74,311 | 98,663 | 142,547 | 173,697 | 187,823 | 216,970 | 250,673 | 272,117 | 304,611 | 328,566 | 364,255 | 381,027 | 415,961 |
| Stock & work in progress | 59,479 | 65,894 | 57,325 | 55,394 | 43,993 | 44,311 | 49,758 | 45,223 | 44,604 | 41,069 | 43,298 | 36,344 | |||
| Trade Debtors | 576,277 | 517,629 | 465,865 | 187,333 | 190,604 | 181,064 | 122,442 | 188,088 | 145,623 | 118,456 | 120,586 | 117,394 | 85,656 | 134,392 | 77,844 |
| Group Debtors | |||||||||||||||
| Misc Debtors | |||||||||||||||
| Cash | 56,220 | 186,211 | 102,293 | 146,499 | 71,038 | 39,989 | 37,169 | 33,651 | 33,697 | 142,848 | 51,192 | 36,171 | |||
| misc current assets | |||||||||||||||
| total current assets | 576,277 | 517,629 | 465,865 | 303,032 | 442,709 | 340,682 | 324,335 | 303,119 | 229,923 | 205,383 | 199,460 | 195,695 | 269,573 | 228,882 | 150,359 |
| total assets | 601,659 | 567,472 | 540,176 | 401,695 | 585,256 | 514,379 | 512,158 | 520,089 | 480,596 | 477,500 | 504,071 | 524,261 | 633,828 | 609,909 | 566,320 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 185,404 | 232,179 | 257,160 | 174,352 | 179,418 | 140,521 | 140,359 | 184,202 | 138,920 | 152,075 | 229,403 | 304,898 | 426,924 | 419,324 | 408,261 |
| Group/Directors Accounts | |||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | |||||||||||||||
| total current liabilities | 185,404 | 232,179 | 257,160 | 174,352 | 179,418 | 140,521 | 140,359 | 184,202 | 138,920 | 152,075 | 229,403 | 304,898 | 426,924 | 419,324 | 408,261 |
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | 153 | 560 | |||||||||||||
| total long term liabilities | 153 | 560 | |||||||||||||
| total liabilities | 185,404 | 232,179 | 257,160 | 174,352 | 179,418 | 140,521 | 140,359 | 184,202 | 138,920 | 152,075 | 229,403 | 304,898 | 427,077 | 419,324 | 408,821 |
| net assets | 416,255 | 335,293 | 283,016 | 227,343 | 405,838 | 373,858 | 371,799 | 335,887 | 341,676 | 325,425 | 274,668 | 219,363 | 206,751 | 190,585 | 157,499 |
| total shareholders funds | 416,255 | 335,293 | 283,016 | 227,343 | 405,838 | 373,858 | 371,799 | 335,887 | 341,676 | 325,425 | 274,668 | 219,363 | 206,751 | 190,585 | 157,499 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | Jun 2012 | Jun 2011 | Jun 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 348 | 7,150 | 9,356 | 5,243 | 10,235 | 12,565 | 10,147 | 9,105 | 11,689 | 15,266 | 12,938 | 16,470 | |||
| Amortisation | 24,000 | 24,000 | 24,000 | 24,000 | 24,000 | 24,000 | 24,000 | 24,000 | 24,000 | 24,000 | 24,000 | 24,000 | |||
| Tax | |||||||||||||||
| Stock | -59,479 | -6,415 | 8,569 | 1,931 | 11,401 | -318 | -5,447 | 4,535 | 619 | 3,535 | -2,229 | 6,954 | 36,344 | ||
| Debtors | 58,648 | 51,764 | 278,532 | -3,271 | 9,540 | 58,622 | -65,646 | 42,465 | 27,167 | -2,130 | 3,192 | 31,738 | -48,736 | 56,548 | 77,844 |
| Creditors | -46,775 | -24,981 | 82,808 | -5,066 | 38,897 | 162 | -43,843 | 45,282 | -13,155 | -77,328 | -75,495 | -122,026 | 7,600 | 11,063 | 408,261 |
| Accruals and Deferred Income | |||||||||||||||
| Deferred Taxes & Provisions | -153 | 153 | -560 | 560 | |||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | |||||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | -56,220 | -129,991 | 83,918 | -44,206 | 75,461 | 31,049 | 2,820 | 3,518 | -46 | -109,151 | 91,656 | 15,021 | 36,171 | ||
| overdraft | |||||||||||||||
| change in cash | -56,220 | -129,991 | 83,918 | -44,206 | 75,461 | 31,049 | 2,820 | 3,518 | -46 | -109,151 | 91,656 | 15,021 | 36,171 |
gamlingay pharmacy limited Credit Report and Business Information
Gamlingay Pharmacy Limited Competitor Analysis
Perform a competitor analysis for gamlingay pharmacy limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in HA2 area or any other competitors across 12 key performance metrics.
gamlingay pharmacy limited Ownership
GAMLINGAY PHARMACY LIMITED group structure
Gamlingay Pharmacy Limited has no subsidiary companies.
gamlingay pharmacy limited directors
Gamlingay Pharmacy Limited currently has 3 directors. The longest serving directors include Mr Rushab Shah (Apr 2021) and Mr Aswin Shah (Apr 2021).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Rushab Shah | England | 34 years | Apr 2021 | - | Director |
| Mr Aswin Shah | England | 71 years | Apr 2021 | - | Director |
| Mr Mahesh Shah | 69 years | Apr 2021 | - | Director |
P&L
March 2024turnover
2.5m
+11%
operating profit
107.9k
0%
gross margin
26.3%
-3.51%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
416.3k
+0.24%
total assets
601.7k
+0.06%
cash
0
0%
net assets
Total assets minus all liabilities
gamlingay pharmacy limited company details
company number
05467439
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
May 2005
age
20
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
60a ashleigh mann, station road, north harrow, HA2 7SL
Bank
HSBC BANK PLC
Legal Advisor
-
gamlingay pharmacy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to gamlingay pharmacy limited. Currently there are 2 open charges and 0 have been satisfied in the past.
gamlingay pharmacy limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for GAMLINGAY PHARMACY LIMITED. This can take several minutes, an email will notify you when this has completed.
gamlingay pharmacy limited Companies House Filings - See Documents
| date | description | view/download |
|---|
